Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nuclear Medicine Communications|May 7, 2021
Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?Savaş Karyağar, Osman Güven, Sevda Sağlampinar Karyağar, et al.
European Journal of Clinical Pharmacology|December 15, 2022
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancerDilek Çağlayan, Mehmet Zahid Koçak, Çağlayan Geredeli, et al.
Annali Italiani Di Chirurgia|December 26, 2024
Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast CancerZuhat Urakçı, Muhammet Ali Kaplan, Zeynep Oruç, et al.
Journal of Cancer Research and Therapeutics|October 3, 2023
The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancerMustafa Karaağaç, Çağlayan Geredeli, Mahmut Selman Yıldırım, et al.
Future Oncology (London, England)|September 24, 2024
The impact of body mass index on the progression-free survival of CDK 4/6 inhibitors in metastatic breast cancer patientsDilek Çağlayan, Mehmet Zahid Koçak, Çağlayan Geredeli, et al.
European Journal of Breast Health|April 19, 2021
Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective StudyMuhammed Mustafa Atcı, Çağlayan Geredeli, Seval Ay, et al.
The New England Journal of Medicine|March 11, 2026
Romiplostim versus Placebo for Chemotherapy-Induced ThrombocytopeniaHanny Al-Samkari, César Muñoz, Çağlayan Geredeli, et al.
Medicina (Kaunas, Lithuania)|January 28, 2026
The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life StudyEngin Hendem, Mehmet Zahid Koçak, Ayşegül Merç Çetinkaya, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2021
Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neckSema Sezgin Göksu, Ali Murat Tatlı, Çağlayan Geredeli, et al.
Journal of Cancer Research and Clinical Oncology|May 15, 2023
The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter studyMuzaffer Uğraklı, Mehmet Zahid Koçak, Gülhan Dinç, et al.
Pageof 2